Fingerprint
Dive into the research topics of 'Durable response rate as an endpoint in cancer immunotherapy: Insights from oncolytic virus clinical trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Durable response rate as an endpoint in cancer immunotherapy: Insights from oncolytic virus clinical trials
Howard L. Kaufman, Robert H.I. Andtbacka, Frances A. Collichio, Michael Wolf, Zhongyun Zhao, Mark Shilkrut, Igor Puzanov, Merrick Ross
Research output: Contribution to journal › Article › peer-review
35
Scopus
citations